ICIG Completes Acquisition of Sandoz Industrial Products GmbH

April 4, 2016
Pharmaceutical Technology Editors

Sandoz Industrial Products GmbH will be renamed Corden BioChem and will be associated with the CordenPharma Group, ICIG’s pharmaceutical platform.

On April 1, 2016, International Chemical Investors Group (ICIG) announced the completion of its acquisition of Sandoz Industrial Products GmbH, a Frankfurt-Höchst-based manufacturer of enzyme fermentation products and intermediates for the pharmaceutical industry, from Novartis Group.

Sandoz Industrial Products will be renamed Corden BioChem GmbH and will be associated with the CordenPharma Group, the pharmaceutical platform of ICIG. Corden BioChem will be complementary to ICIG’s pharma activities as well as to its fine chemicals activities within the WeylChem Group. According to a press announcement, ICIG is focused on the development of Corden BioChem with the enzymatic 7-ACA businesses for antibiotics applications at the Höchst site as well as the CordenPharma Latina site in Italy.

Source: ICIG

Related Content:

PharmTech News | Supplier News